Quantitative analysis of SMN2 based on real-time PCR: Correlation of clinical severity and SMN2 gene dosage

No To Hattatsu

Volumn 37, Issue 5, 2005, Pages 407-412

  Saito, Makiko ^a   Chen, Yuyan ^a   Mizuguchi, Masashi ^a   Igarashi, Takashi ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

SURVIVAL MOTOR NEURON PROTEIN;

ARTICLE; ARTIFICIAL VENTILATION; AUTOSOMAL DOMINANT INHERITANCE; DISEASE SEVERITY; GENE; GENE DELETION; GENE DOSAGE; HUMAN; ONSET AGE; PEDIGREE; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SINGLE STRAND CONFORMATION POLYMORPHISM; SMN1 GENE; SMN2 GENE; SPINAL MUSCULAR ATROPHY;

CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; FEMALE; GENE DOSAGE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; NERVE TISSUE PROTEINS; POLYMERASE CHAIN REACTION; RNA-BINDING PROTEINS; SEVERITY OF ILLNESS INDEX; SPINAL MUSCULAR ATROPHIES OF CHILDHOOD;

EID: 25144523447     PISSN: 00290831     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Munsat TL, Davies KE. International SMA Consortium Meeting (26-28 June 1992, Bonn, Germany). Neuromuscl Disord 1992;2:423-8.
2. Zerres K, Rudnig-Shoneborn S. Natural history in proximal spinal (SMA): clinical analysis of 445 patients and suggestions for a modification of existing classifications. Arch Neurol 1995; 52: 518-23.
3. Lefebvre S, Burglen L, Reboullet S, et al. Identification and characterization of a spinal muscular atrophy-determining gene. Cell 1995; 80: 155-65.
4. Burglen L, Lefebvre S, Clermont O, et al. Structure and organization of the human survival motor neuron (SMN) gene. Genomics 1996; 32: 479-82.
5. Scheffer H, Cobben JM, Matthijs G, Wirth B. Best practice guidelines for molecular analysis in spinal muscular atrophy. Eur J Hum Genet 2001; 9: 484-91.
6. Wirth B, Herz M, Wetter A, et al. Quantitative analysis of survival motor neuron copies: identification of subtle SMN1 mutations in patients with spinal muscular atrophy, genotype-phenotype correlation, and implications for genetic counseling. Am J Hum Genet 1999; 64: 1340-56.
7. Coovert DD, Le TT, McAndrew PE, et al. The survival motor neuron protein in spinal muscular atrophy. Hum Mol Genet 1997; 6: 1205-14.
8. Hsieh-Li HM, Chang JG, Jong YJ, et al. A mouse model for spinal muscular atrophy. Nat Genet 2000; 24: 66-70.
9. Lorson CL, Hahnen E, Androphy EJ, Wirth B. A single nucleotide in the SMN gene regulates splicing and is responsible for spinal muscular atrophy. Proc Natl Acad Sci USA 1999; 96: 6307-11.
10. Campbell L, Potter A, Ignatius J, Dubowitz V, Davies K. Genomic variation and gene conversion in spinal muscular atrophy: implications for disease process and clinical phenotype. Am J Hum Genet 1997; 61: 40-50.
11. Velasco E, Valero C, Valero A, Moreno F, Hernandez-Chico C. Molecular analysis of the SMN and NAIP genes in Spanish spinal muscular atrophy (SMA) families and correlation between number of copies of CBCD541 and SMA phenotype. Hum Mol Genet 1996; 5: 257-63.
12. McAndrew PE, Parsons DW, Simard LR, et al. Identification of proximal spinal muscular atrophy carriers and patients by analysis of SMNT and SMNC gene copy number. Am J Hum Genet 1997; 60: 1411-22.
13. Diep Tran T, Kroepfl T, Saito M, et al. The gene copy ratios of SMN1/SMN2 in Japanese carriers with Type I spinal muscular atrophy. Brain Dev 2001; 23: 321-6.
14. Van der Steege G, Grootscholten PM, van der Vlies P, et al. PCR-based DNA test to confirm clinical diagnosis of autosomal recessive spinal muscular atrophy. Lancet 1995; 345: 985-6.
15. Feldkotter M, Schwarzer V, Wirth R, Wienker TF, Wirth B. Quantitative analysis of SMN1 and SMN2 based on real-time lightcycler PCR: fast and highly reliable carrier testing and prediction severity of spinal muscular atrophy. Am J Hum Genet 2002; 70: 358-68.
16. Hofmann Y, Lorson CL, Stamm S, Androphy FJ, Wirth B. Htra2-beta 1 stimulates an exonic splicing enhancer and can restore full-length SMN expression to survival motor neuron 2 (SMN2). Proc Natl Acad Sci USA 2000; 97: 9618-23.
17. Chang JG, Hsieh-Li HM, Jong YJ, Wang NM, Tsai CH, Li H. Treatment of spinal muscular atrophy by sodium butyrate. Proc Natl Acad Sci USA 2001; 98: 9808-13.
18. Harada Y, Sutomo R, Sadewa AH et al. Correlation between SMN2 copy number and clinical phenotype of spinal muscular atrophy: three SMN2 copies fail to rescue some patients from the disease severity. J Neurol 2002; 249: 1211-9.